ArticleOncotarget2018

Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus.

Sarah L Hulin-Curtis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.